1-4 of 4
Peter C. Kohler
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Altered Tryptophan and Neopterin Metabolism in Cancer Patients Treated with Recombinant Interleukin 2

Raymond R. Brown, Caroll M. Lee, Peter C. Kohler, Jaquelyn A. Hank, Barry E. Storer, Paul M. Sondel
Journal: Cancer Research
Cancer Res (1989) 49 (17): 4941–4944.
Published: 01 September 1989
View article titled, Altered Tryptophan and Neopterin Metabolism in Cancer Patients Treated with Recombinant Interleukin 2
Open the PDF for Altered Tryptophan and Neopterin Metabolism in Cancer Patients Treated with Recombinant Interleukin 2 in another window
Journal Articles

Clinical and Immunological Effects of Recombinant Interleukin 2 Given by Repetitive Weekly Cycles to Patients with Cancer

Paul M. Sondel, Peter C. Kohler, Jacquelyn A. Hank, Karen H. Moore, Nancy S. Rosenthal, Jeff A. Sosman, Robin Bechhofer, Barry Storer
Journal: Cancer Research
Cancer Res (1988) 48 (9): 2561–2567.
Published: 01 May 1988
View article titled, Clinical and Immunological Effects of Recombinant Interleukin 2 Given by Repetitive Weekly Cycles to Patients with Cancer
Open the PDF for Clinical and Immunological Effects of Recombinant Interleukin 2 Given by Repetitive Weekly Cycles to Patients with Cancer in another window
Journal Articles

In Vivo Induction of the Lymphokine-activated Killer Phenomenon: Interleukin 2-dependent Human Non-Major Histocompatibility Complex-restricted Cytotoxicity Generated in Vivo during Administration of Human Recombinant Interleukin 2

Jacquelyn A. Hank, Peter C. Kohler, Gilda Weil-Hillman, Nancy Rosenthal, Karen H. Moore, Barry Storer, Debbie Minkoff, Jeff Bradshaw, Robin Bechhofer, Paul M. Sondel
Journal: Cancer Research
Cancer Res (1988) 48 (7): 1965–1971.
Published: 01 April 1988
View article titled, <em>In Vivo</em> Induction of the Lymphokine-activated Killer Phenomenon: Interleukin 2-dependent Human Non-Major Histocompatibility Complex-restricted Cytotoxicity Generated <em>in Vivo</em> during Administration of Human Recombinant Interleukin 2
Open the PDF for <em>In Vivo</em> Induction of the Lymphokine-activated Killer Phenomenon: Interleukin 2-dependent Human Non-Major Histocompatibility Complex-restricted Cytotoxicity Generated <em>in Vivo</em> during Administration of Human Recombinant Interleukin 2 in another window
Journal Articles

In Vitro Analysis of Donor Bone Marrow following Monoclonal Antibody Treatment for the Prevention of Acute Graft versus Host Disease

Peter C. Kohler, Christene Erickson, Johnathan L. Finlay, Michael E. Trigg, Bruce Edwards, Richard Hong, Jacquelyn A. Hank, Ronald Billing, Marek Bozdech, Paul M. Sondel
Journal: Cancer Research
Cancer Res (1986) 46 (10): 5413–5418.
Published: 01 October 1986
View article titled, <em>In Vitro</em> Analysis of Donor Bone Marrow following Monoclonal Antibody Treatment for the Prevention of Acute Graft <em>versus</em> Host Disease
Open the PDF for <em>In Vitro</em> Analysis of Donor Bone Marrow following Monoclonal Antibody Treatment for the Prevention of Acute Graft <em>versus</em> Host Disease in another window